We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Crism Therapeutics Corp | AQSE:AMC.GB | Aquis Stock Exchange | Ordinary Share | VGG042401262 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 11.00 | 8.00 | 14.00 | 11.00 | 11.00 | 11.00 | 0.00 | 06:59:38 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Dec 2022 to Dec 2024
TIDMAMC
RNS Number : 1497T
Amur Minerals Corporation
13 November 2023
13 November 2023
Amur Minerals Corporation
("Amur" or "the Company")
Notice of Annual General Meeting
Amur Minerals Corporation (AIM: AMC) is pleased to announce that the Company's Annual General Meeting will be held at 10:00 a.m. (GMT) on 30 November 2023 at the offices of Fieldfisher LLP, Riverbank House, 2 Swan Lane, London, EC4R 3TT, UK.
The Notice of Annual General Meeting will be posted to Shareholders today. Details of the resolutions for consideration can be downloaded from the Company's website, www.amurminerals.com .
Enquiries:
Hot Features
Premium
Company Nomad and Broker Public Relations
Amur Minerals Corp. S.P. Angel Corporate BlytheRay
Finance LLP
Robin Young CEO Richard Morrison Megan Ray
Adam Cowl Tim Blythe
+44 (0) 20 3470
+1 (925) 408-4621 0470 +44 (0) 20 7138 3203
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NOAURUBROKUAAAA
(END) Dow Jones Newswires
November 13, 2023 02:00 ET (07:00 GMT)
1 Year Crism Therapeutics Chart |
1 Month Crism Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
